Phillip G. Billington - Nov 10, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP-Internal Audit Services
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Nov 10, 2023
Transactions value $
-$875,259
Form type
4
Date filed
11/14/2023, 06:16 PM
Previous filing
Feb 22, 2023
Next filing
Feb 2, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $577K +12K +27.28% $47.97* 56.1K Nov 10, 2023 Direct F1
transaction HCA Common Stock Tax liability -$1.45M -6.24K -11.12% $232.82 49.9K Nov 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -6.5K -100% $0.00* 0 Nov 10, 2023 Common Stock 6.5K $47.97 Direct F2
transaction HCA Stock Appreciation Right Options Exercise $0 -5.53K -100% $0.00* 0 Nov 10, 2023 Common Stock 5.53K $47.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F3 The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.